Evidence map›Paper›PMID 26378785›Full record

ArticlePloS one2015

Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1.

Karen M Lammers, Marcello Chieppa, Lunhua Liu, Song Liu, Tatsushi Omatsu, Mirkka Janka-Junttila, Vincenzo Casolaro, Hans-Christian Reinecker, Carole A Parent, Alessio Fasano

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. IL7RBrain and behavior · 2025
    Article
  3. Article
  4. TheFrontiers in immunology · 2025
    Review
  5. Article
  6. Article
  7. Probiotics to Prevent Celiac Disease and Inflammatory Bowel Diseases.Advances in experimental medicine and biology · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Formyl peptide receptors in the mucosal immune system.Experimental & molecular medicine · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Genetic and Environmental Contributors for Celiac Disease.Current allergy and asthma reports · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Karen M LammersDepartment of Pediatrics, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital East, Charlestown, Massachusetts, United States of America.
Marcello ChieppaLymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Lunhua LiuLaboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
Song LiuDepartment of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Tatsushi OmatsuDepartment of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Mirkka Janka-JunttilaLaboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
Vincenzo CasolaroDepartment of Pediatrics, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital East, Charlestown, Massachusetts, United States of America.
Hans-Christian ReineckerDepartment of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Carole A ParentLaboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
Alessio FasanoDepartment of Pediatrics, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital East, Charlestown, Massachusetts, United States of America.
Massachusetts General Hospital · USCenter for Cancer Research · USNational Institutes of Health · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Xenograft and Isograft CoreP01DK033506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 1986 to 2015
$24.2M
CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATIONZIABC011216 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PARENT, CAROLE · 2009 to 2017
$8.6M
Innate Immune Defense Mechanisms in the IntestineR01AI113333 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI REINECKER, HANS-CHRISTIAN · 2014 to 2025
$5.7M
Antigen Recognition at Intestinal Epithelial InterphasesR01DK068181 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 2005 to 2017
$5.2M
Zot, Zonulin, and Pathophysiology of Intestinal Tight JunctionsR01DK048373 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI FASANO, ALESSIO · 1996 to 2015
$4.4M
Timing of Gluten Intake In Infant Nutrition and Risk of Celiac Disease AutoimmuniR21DK078699 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI FASANO, ALESSIO · 2008 to 2009
$413k
Intramural NIH HHSNIAID NIH HHS AI113333NIAID NIH HHS R01 AI113333NIDDK NIH HHS DK033506NIDDK NIH HHS DK043351NIDDK NIH HHS DK068181NIDDK NIH HHS DK-078699NIDDK NIH HHS DK-48373NIDDK NIH HHS P01 DK033506NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK048373NIDDK NIH HHS R01 DK068181NIDDK NIH HHS R21 DK078699
6 · The paper itself

Abstract

backgroundGliadin, the immunogenic component within gluten and trigger of celiac disease, is known to induce the production of Interleukin-8, a potent neutrophil-activating and chemoattractant chemokine. We sought to study the involvement of neutrophils in the early immunological changes following gliadin exposure.

methodsUtilizing immunofluorescence microscopy and flow cytometry, the redistribution of major tight junction protein, Zonula occludens (ZO)-1, and neutrophil recruitment were assessed in duodenal tissues of gliadin-gavaged C57BL/6 wild-type and Lys-GFP reporter mice, respectively. Intravital microscopy with Lys-GFP mice allowed monitoring of neutrophil recruitment in response to luminal gliadin exposure in real time. In vitro chemotaxis assays were used to study murine and human neutrophil chemotaxis to gliadin, synthetic alpha-gliadin peptides and the neutrophil chemoattractant, fMet-Leu-Phe, in the presence or absence of a specific inhibitor of the fMet-Leu-Phe receptor-1 (FPR1), cyclosporine H. An irrelevant protein, zein, served as a control.

resultsRedistribution of ZO-1 and an influx of CD11b+Lys6G+ cells in the lamina propria of the small intestine were observed upon oral gavage of gliadin. In vivo intravital microscopy revealed a slowing down of GFP+ cells within the vessels and influx in the mucosal tissue within 2 hours after challenge. In vitro chemotaxis assays showed that gliadin strongly induced neutrophil migration, similar to fMet-Leu-Phe. We identified thirteen synthetic gliadin peptide motifs that induced cell migration. Blocking of FPR1 completely abrogated the fMet-Leu-Phe-, gliadin- and synthetic peptide-induced migration.

conclusionsGliadin possesses neutrophil chemoattractant properties similar to the classical neutrophil chemoattractant, fMet-Leu-Phe, and likewise uses FPR1 in the process.

Indexed as

AnimalsCD11b AntigenCeliac DiseaseCell MovementChemotactic FactorsChemotaxis, LeukocyteDuodenumGliadinHumansIntestine, SmallMiceMice, Inbred C57BLNeutrophil InfiltrationNeutrophilsN-Formylmethionine Leucyl-PhenylalaninePeptide FragmentsCD11b AntigenChemotactic FactorsFpr1 protein, mouseGliadinN-Formylmethionine Leucyl-PhenylalaninePeptide FragmentsReceptors, Formyl PeptideTjp1 protein, mouseZonula Occludens-1 Protein

Identifiers

PMID26378785
PMCPMC4574934
OpenAlexW2217729497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.